My Clinical Outcomes Revenue and Competitors

London, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • My Clinical Outcomes's estimated annual revenue is currently $1.5M per year.(i)
  • My Clinical Outcomes's estimated revenue per employee is $87,000

Employee Data

  • My Clinical Outcomes has 17 Employees.(i)
  • My Clinical Outcomes grew their employee count by 6% last year.

My Clinical Outcomes's People

NameTitleEmail/Phone
1
Co-founder & CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.2M630%N/AN/A
#2
$3.8M33-33%N/AN/A
#3
$293.3M1445-12%N/AN/A
#4
$1.7M19-17%N/AN/A
#5
$13.1M90-11%N/AN/A
#6
$6.7M5138%N/AN/A
#7
$14.1M973%N/AN/A
#8
$5.1M4447%N/AN/A
#9
$16.7M115-78%N/AN/A
#10
$23.3M14626%N/AN/A
Add Company

What Is My Clinical Outcomes?

My Clinical Outcomes (MCO) is a web-based platform for routine measurement and analytics of patient reported outcome measures in clinical practice. MCO allows patients to remotely quantify and track the outcomes that are important to them before, during and following treatment. Real-time reporting allows clinicians to optimise the care of their individual patients, while the resultant insight can be used by managers and payers to improve the overall value of delivered care. MCO works across all specialties and conditions and is accredited by the UK Private Healthcare Information Network (PHIN) and the International Consortium of Health Outcomes Measurements (ICHOM). For more information and user reviews see ICHOM TechHub: http://techhub.ichom.org/directory/listing/my-clinical-outcomes

keywords:N/A

N/A

Total Funding

17

Number of Employees

$1.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

My Clinical Outcomes News

2022-04-20 - Forge Health Announces Transformative Clinical Outcomes ...

“In my over 30 years of experience in the addiction and mental health field, I have never seen study results that demonstrate such a significant...

2022-04-20 - A potential way for overcoming immunotherapy resistance in patients with mucosal melanomas

... by decitabine will enhance the killing capacity of MAIT cells and improve clinical outcomes for mucosal melanoma patients," Tobin says.

2022-03-30 - Omicron 'less severe' than Delta for children ages 4 and younger ...

The findings show that the Omicron variant is 6-8 times more infectious than the Delta variant. The severe clinical outcomes ranged from a 16%...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17-11%N/A
#2
$1.3M17N/A$8M
#3
$1.5M170%N/A
#4
$1.5M17-41%N/A
#5
$2.2M17-6%N/A